Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel, Cisplatin, and Fluorouracil in Nasopharyngeal Carcinoma
NCT04004871Phase 2Completed
- Sponsor
- Guangxi Medical University
- Start
- Mar 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in nasopharyngeal carcinoma (NPC), sponsored by Guangxi Medical University. Started Mar 2019; status: completed.
02
Drugs
paclitaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04004871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04004871.